Related references
Note: Only part of the references are listed.Metabolic and hormonal side effects of mitotane treatment for adrenocortical carcinoma: A retrospective study in 50 Danish patients
Malene Elbaek Vikner et al.
CLINICAL ENDOCRINOLOGY (2021)
Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
Przemyslaw J. Danek et al.
PHARMACOLOGICAL REPORTS (2021)
Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Yongfeng Song et al.
CELL METABOLISM (2021)
Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library
Caitlin Lynch et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2-mediated mechanism
Mikko Karpale et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The xenobiotic receptors PXR and CAR in liver physiology, an update
Xinran Cai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia
Maiko Abumiya et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
The PCSK9 revolution: Current status, controversies, and future directions
Bruce A. Warden et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Nuclear receptors are the major targets of endocrine disrupting chemicals
Lucia Toporova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Mechanisms and regulation of cholesterol homeostasis
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer
Ignacio Duran et al.
CLINICAL PHARMACOKINETICS (2020)
Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity
Fatemeh Hassani-Nezhad-Gashti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters
Tuire Salonurmi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1
Shiori Sato et al.
PHARMACOLOGICAL REPORTS (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome
Janne Hukkanen et al.
CELLS (2020)
Inhibition and induction of CYP enzymes in humans: an update
Jukka Hakkola et al.
ARCHIVES OF TOXICOLOGY (2020)
Mechanistic Insights of Phenobarbital-Mediated Activation of Human but Not Mouse Pregnane X Receptor
Linhao Li et al.
MOLECULAR PHARMACOLOGY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Nutritional status modifies pregnane X receptor regulated transcriptome
Fatemeh Hassani-Nezhad-Gashti et al.
SCIENTIFIC REPORTS (2019)
Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
Taesik Gwag et al.
JOURNAL OF HEPATOLOGY (2019)
The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling
Zhaojie Meng et al.
JCI INSIGHT (2019)
Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol
Angela Rowland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients
Vinaya Simha et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2017)
A conserved degron containing an amphipathic helix regulates the cholesterol-mediated turnover of human squalene monooxygenase, a rate-limiting enzyme in cholesterol synthesis
Ngee Kiat Chua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach
Gurpreet K. Grewal et al.
PHARMACEUTICAL RESEARCH (2017)
Epidemiology of ischemic heart disease in HIV
Virginia A. Triant et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
Simon Glerup et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia
Maaike Kockx et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Lipids in liver transplant recipients
Anna Huesing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
Zhuofeng Lin et al.
CIRCULATION (2015)
Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
A. Sahebkar et al.
DIABETES OBESITY & METABOLISM (2015)
Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
Juan Pablo Domecq et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis
Sjoerd C. Heslinga et al.
JOURNAL OF RHEUMATOLOGY (2015)
Intestinal Pregnane X Receptor Links Xenobiotic Exposure and Hypercholesterolemia
Yipeng Sui et al.
MOLECULAR ENDOCRINOLOGY (2015)
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion
Ryan E. Temel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
mTOR inhibitors and dyslipidemia in transplant recipients: A cause for concern?
Hallvard Holdaas et al.
TRANSPLANTATION REVIEWS (2015)
A potential mechanism underlying atypical antipsychotics-induced lipid disturbances
H. L. Cai et al.
TRANSLATIONAL PSYCHIATRY (2015)
Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
Andreas Bitter et al.
ARCHIVES OF TOXICOLOGY (2015)
Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro
Dirk Theile et al.
ENDOCRINE (2015)
Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects
Sreeneeranj Kasichayanula et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Profiling of enantiopure drugs towards aryl hydrocarbon (AhR), glucocorticoid (GR) and pregnane X (PXR) receptors in human reporter cell lines
Aneta Novotna et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
PCSK9: A Key Modulator of Cardiovascular Health
Nabil G. Seidah et al.
CIRCULATION RESEARCH (2014)
HIV infection and cardiovascular disease
Lars G. Hemkens et al.
EUROPEAN HEART JOURNAL (2014)
The Effect of Single-and Multiple-Dose Etravirine on a Drug Cocktail of Representative Cytochrome P450 Probes and Digoxin in Healthy Subjects
Thomas N. Kakuda et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Omeprazole and Lansoprazole Enantiomers Induce CYP3A4 in Human Hepatocytes and Cell Lines via Glucocorticoid Receptor and Pregnane X Receptor Axis
Aneta Novotna et al.
PLOS ONE (2014)
The effects of antiepileptic drugs on vascular risk factors: A narrative review
Niki Katsiki et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)
Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report
Sukhmani K. Padda et al.
ANTI-CANCER DRUGS (2013)
Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors
Devinder Sharma et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Pregnane X Receptor Agonists Impair Postprandial Glucose Tolerance
J. Rysa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors
S. Harmsen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
Vasileios Chortis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Jamie Robertson et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
T. Scott Stroup et al.
SCHIZOPHRENIA RESEARCH (2013)
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
Heather A. Wakelee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses
Nathanael J. Spann et al.
CELL (2012)
Connecting mTORC1 signaling to SREBP-1 activation
Inan Bakan et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Chronic Exposure to Rifaximin Causes Hepatic Steatosis in Pregnane X Receptor-Humanized Mice
Jie Cheng et al.
TOXICOLOGICAL SCIENCES (2012)
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Lin Jia et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B-Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Anne-Laure Sberna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
Chibueze A. Ihunnah et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
Matthias Kroiss et al.
CLINICAL ENDOCRINOLOGY (2011)
Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs via Ligand-Based Virtual Screening
Yongmei Pan et al.
DRUG METABOLISM AND DISPOSITION (2011)
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Sunita J. Shukla et al.
DRUG METABOLISM AND DISPOSITION (2011)
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
Nielka P. van Erp et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts
Jinhan He et al.
GASTROENTEROLOGY (2011)
Effect of Antipsychotic Medications on Glucose and Lipid Levels
Parminder S. Chaggar et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
Anne Laure Sberna et al.
JOURNAL OF HEPATOLOGY (2011)
Changes in Serum Triglyceride and Cholesterol Levels during Long-Term Phenytoin Treatment for Epilepsy
P. V. Luoma et al.
ACTA MEDICA SCANDINAVICA (2010)
Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin
B. O'Neill et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population
Yingchang Lu et al.
ATHEROSCLEROSIS (2010)
Explaining variability in ciclosporin exposure in adult kidney transplant recipients
Rogier R. Press et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Nuclear Receptor-Mediated Induction of CYP450 by Antiretrovirals: Functional Consequences of NR1I2 (PXR) Polymorphisms and Differential Prevalence in Whites and Sub-Saharan Africans
Jenny Svaerd et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
Bin Dong et al.
JOURNAL OF LIPID RESEARCH (2010)
The PXR is a drug target for chronic inflammatory liver disease
Karen Wallace et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine
Monika Scholler-Gyure et al.
CLINICAL PHARMACOKINETICS (2009)
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
S. Le Hellard et al.
MOLECULAR PSYCHIATRY (2009)
Atherosclerotic risk among children taking antiepileptic drugs
Tomasz Jakubus et al.
PHARMACOLOGICAL REPORTS (2009)
Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway
Kun Wang et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans
Patrick J. Roberts et al.
DRUG METABOLISM AND DISPOSITION (2008)
Regulatory cross-talk between drug metabolism and lipid homeostasis:: Constitutive androstane receptor and pregnane X receptor increase Insig-1 expression
Adrian Roth et al.
MOLECULAR PHARMACOLOGY (2008)
Rifaximin is a gut-specific human pregnane X receptor activator
Xiaochao Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis
Omer Deniz et al.
CLINICAL BIOCHEMISTRY (2007)
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine
Mikael Oscarson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
Eric Dailly et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway
Jie Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study
Athanasios N. Georgiadis et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites
J Sonoda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients
J Fellay et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription
TG Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor
C Solas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital
N Hariparsad et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α -: Functional implications in hepatic cholesterol and glucose metabolism
S Bhalla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation
D Anglicheau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Increase in tacrolimus trough levels after steroid withdrawal
EM van Duijnhoven et al.
TRANSPLANT INTERNATIONAL (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects
XP Chen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Accelerated degradation of HMG CoA reductase mediated by binding of Insig-1 to its sterol-sensing domain
N Sever et al.
MOLECULAR CELL (2003)
Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans
S Mouly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Control of cholesterol turnover in the mouse
JM Dietschy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor
HR Kast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR
I Dussault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
JL Staudinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
W Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone
JS McCune et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes:: Synergistic increase of CYP3A4 induction by pregnane X receptor activators
JM Pascussi et al.
MOLECULAR PHARMACOLOGY (2000)
The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy
J Eirís et al.
EPILEPSY RESEARCH (2000)